Lanean...
Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
Advances in the treatment of rheumatoid arthritis (RA) are attributed to several aspects such as new classification criteria enabling early diagnosis and intensive treatment with the application of treat-to-target principles as well as better understanding of the pathogenesis of RA contributing to t...
Gorde:
| Argitaratua izan da: | F1000Res |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
F1000 Research Limited
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719675/ https://ncbi.nlm.nih.gov/pubmed/31508202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.18688.1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|